Is Bio-Techne Corp a good dividend stock?

Bio-Techne Corp (TECH) is a dividend-paying stock with a current dividend yield of 0.55%. Review its dividend history, payout consistency and growth to judge whether it fits your income strategy.

What is TECH's dividend yield?

The dividend yield for TECH stock is currently 0.55%.

How much does TECH pay in dividends per year?

Bio-Techne Corp pays an annual dividend of $0.4000 per share over the trailing twelve months.

How often does TECH pay dividends?

TECH stock pays dividends quarterly.

Is TECH's dividend growing?

Bio-Techne Corp's 3-year dividend CAGR is 7.72%.

TECH Stock Price, Chart, Stats & News

Bio-Techne Corp

Save

Overview Dividend safety Dividends Fundamentals

Bio-Techne Corp (TECH) is a dividend-paying stock with a current dividend yield of 0.55% as of Sep 29, 2026. It pays $0.4000 per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 4.56% 5-year compound annual rate.

11.33B

Market cap

37.31x

Current P/E

34.60x

Forward P/E

0.55%

Dividend yield

$0.4000

TECH dividend

Dividend safety

Strong

Dividend coverage looks healthy — TECH pays out about 21% of earnings.

See the safety analysis

TECH chart

Fundamentals

Gross margin	65.22%
Operating margin	9.62%
Pretax margin	9.39%
Net margin	6.67%
Effective tax rate	28.97%
ROA	3.21%
ROE	4.10%
D/E	0.17x
Interest coverage ratio	12.59x

All financials

TECH valuation

P/E	37.31x
P/S	6.56x
P/B	3.95x
P/CF	31.85x
P/FCF	35.74x
P/OCF	31.85x
PEG	24.47x
EV multiple	34.30x

About

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies.